1. Market Research
  2. > Pharmaceutical
  3. > Drug Discovery and Development Market Trends
  4. > Prostatic Intraepithelial Neoplasia Global Clinical Trials Review, H1, 2014

Prostatic Intraepithelial Neoplasia Global Clinical Trials Review, H1, 2014

Summary

GlobalData's clinical trial report, “Prostatic Intraepithelial Neoplasia Global Clinical Trials Review, H1, 2014" provides data on the Prostatic Intraepithelial Neoplasia clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Prostatic Intraepithelial Neoplasia. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Prostatic Intraepithelial Neoplasia. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
- Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
- Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

- Understand the dynamics of a particular indication in a condensed manner
- Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
- Obtain discontinued trial listing for trials across the globe
- Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Table Of Contents

Prostatic Intraepithelial Neoplasia Global Clinical Trials Review, H1, 2014
Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 4
Introduction 5
Prostatic Intraepithelial Neoplasia 5
Report Guidance 5
Clinical Trials by Region 6
Clinical Trials and Average Enrollment by Country 7
Top Five Countries Contributing to Clinical Trials in Europe 9
Top Countries Contributing to Clinical Trials in North America 10
Top Countries Contributing to Clinical Trials in Middle East and Africa 11
Top Countries Contributing to Clinical Trials in Central and South America 12
Clinical Trials by G7 Countries: Proportion of Prostatic Intraepithelial Neoplasia to Oncology Clinical Trials 13
Clinical Trials by Phase in G7 Countries 14
Clinical Trials in G7 Countries by Trial Status 15
Clinical Trials by Phase 16
In Progress Trials by Phase 17
Clinical Trials by Trial Status 18
Clinical Trials by End Point Status 19
Unaccomplished Trials of Prostatic Intraepithelial Neoplasia 20
Subjects Recruited Over a Period of Time 21
Clinical Trials by Sponsor Type 22
Prominent Sponsors 23
Top Companies Participating in Prostatic Intraepithelial Neoplasia Therapeutics Clinical Trials 24
Prominent Drugs 25
Clinical Trial Profiles 26
Clinical Trial Overview of Top Companies 26
GTx, Inc. 26
Clinical Trial Overview of GTx, Inc. 26
SOFAR SPA 27
Clinical Trial Overview of SOFAR SPA 27
ProteoSys AG 28
Clinical Trial Overview of ProteoSys AG 28
Photocure ASA 29
Clinical Trial Overview of Photocure ASA 29
Clinical Trial Overview of Top Institutes / Government 30
University of Pittsburgh 30
Clinical Trial Overview of University of Pittsburgh 30
Southwest Oncology Group 31
Clinical Trial Overview of Southwest Oncology Group 31
Erasmus MC 32
Clinical Trial Overview of Erasmus MC 32
University of the Witwatersrand 33
Clinical Trial Overview of University of the Witwatersrand 33
Institute of Food Research 34
Clinical Trial Overview of Institute of Food Research 34
NCIC Clinical Trials Group 35
Clinical Trial Overview of NCIC Clinical Trials Group 35
Rutgers, The State University of New Jersey 36
Clinical Trial Overview of Rutgers, The State University of New Jersey 36
North Central Cancer Treatment Group 37
Clinical Trial Overview of North Central Cancer Treatment Group 37
Medical University of Vienna 38
Clinical Trial Overview of Medical University of Vienna 38
Five Key Clinical Profiles 39
Appendix 67
Abbreviations 67
Definitions 67
Research Methodology 68
Secondary Research 68
About GlobalData 69
Contact Us 69
Disclaimer 69
Source 70

List of Tables
Prostatic Intraepithelial Neoplasia Therapeutics, Global, Clinical Trials by Region, 2014* 6
Prostatic Intraepithelial Neoplasia Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 7
Prostatic Intraepithelial Neoplasia Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 8
Prostatic Intraepithelial Neoplasia Therapeutics Clinical Trials, Europe, Top Five Countries, 2014* 9
Prostatic Intraepithelial Neoplasia Therapeutics Clinical Trials, North America, Top Countries, 2014* 10
Prostatic Intraepithelial Neoplasia Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2014* 11
Prostatic Intraepithelial Neoplasia Therapeutics Clinical Trials, Central and South America, Top Countries, 2014* 12
Proportion of Prostatic Intraepithelial Neoplasia to Oncology Clinical Trials, G7 Countries (%), 2014* 13
Prostatic Intraepithelial Neoplasia Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 14
Prostatic Intraepithelial Neoplasia Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 15
Prostatic Intraepithelial Neoplasia Therapeutics, Global, Clinical Trials by Phase, 2014* 16
Prostatic Intraepithelial Neoplasia Therapeutics, Global, Clinical Trials In Progress by Phase 2014* 17
Prostatic Intraepithelial Neoplasia Therapeutics, Global, Clinical Trials by Trial Status, 2014* 18
Prostatic Intraepithelial Neoplasia Therapeutics Clinical Trials, Global, by End Point Status, 2014* 19
Prostatic Intraepithelial Neoplasia Therapeutics, Global, Terminated Clinical Trials, 2014* 20
Prostatic Intraepithelial Neoplasia Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 21
Prostatic Intraepithelial Neoplasia Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2014* 22
Prostatic Intraepithelial Neoplasia Therapeutics Clinical Trials, Global, Key Sponsors, 2014* 23
Prostatic Intraepithelial Neoplasia Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014* 24
Prostatic Intraepithelial Neoplasia Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014* 25
Prostatic Intraepithelial Neoplasia Therapeutics Clinical Trials Market, Global, Clinical Trials by GTx, Inc., 2014* 26
Prostatic Intraepithelial Neoplasia Therapeutics Clinical Trials Market, Global, Clinical Trials by SOFAR SPA, 2014* 27
Prostatic Intraepithelial Neoplasia Therapeutics Clinical Trials Market, Global, Clinical Trials by ProteoSys AG, 2014* 28
Prostatic Intraepithelial Neoplasia Therapeutics Clinical Trials Market, Global, Clinical Trials by Photocure ASA, 2014* 29
Prostatic Intraepithelial Neoplasia Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Pittsburgh, 2014* 30
Prostatic Intraepithelial Neoplasia Therapeutics Clinical Trials Market, Global, Clinical Trials by Southwest Oncology Group, 2014* 31
Prostatic Intraepithelial Neoplasia Therapeutics Clinical Trials Market, Global, Clinical Trials by Erasmus MC, 2014* 32
Prostatic Intraepithelial Neoplasia Therapeutics Clinical Trials Market, Global, Clinical Trials by University of the Witwatersrand, 2014* 33
Prostatic Intraepithelial Neoplasia Therapeutics Clinical Trials Market, Global, Clinical Trials by Institute of Food Research, 2014* 34
Prostatic Intraepithelial Neoplasia Therapeutics Clinical Trials Market, Global, Clinical Trials by NCIC Clinical Trials Group, 2014* 35
Prostatic Intraepithelial Neoplasia Therapeutics Clinical Trials Market, Global, Clinical Trials by Rutgers, The State University of New Jersey, 2014* 36
Prostatic Intraepithelial Neoplasia Therapeutics Clinical Trials Market, Global, Clinical Trials by North Central Cancer Treatment Group, 2014* 37
Prostatic Intraepithelial Neoplasia Therapeutics Clinical Trials Market, Global, Clinical Trials by Medical University of Vienna, 2014* 38

List of Figures
Prostatic Intraepithelial Neoplasia Therapeutics, Global, Clinical Trials by Region (%), 2014* 6
Prostatic Intraepithelial Neoplasia Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 7
Prostatic Intraepithelial Neoplasia Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 8
Prostatic Intraepithelial Neoplasia Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2014* 9
Prostatic Intraepithelial Neoplasia Therapeutics Clinical Trials, North America, Top Countries (%), 2014* 10
Proportion of Prostatic Intraepithelial Neoplasia to Oncology Clinical Trials, G7 Countries (%), 2014* 13
Prostatic Intraepithelial Neoplasia Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 14
Prostatic Intraepithelial Neoplasia Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 15
Prostatic Intraepithelial Neoplasia Therapeutics, Global, Clinical Trials by Phase (%), 2014* 16
Prostatic Intraepithelial Neoplasia Therapeutics, Global, Clinical Trials In Progress by Phase, 2014* 17
Prostatic Intraepithelial Neoplasia Therapeutics, Global, Clinical Trials by Trial Status, 2014* 18
Prostatic Intraepithelial Neoplasia Therapeutics Clinical Trials, Global, by End Point Status, 2014* 19
Prostatic Intraepithelial Neoplasia Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 21
Prostatic Intraepithelial Neoplasia Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2014* 22
Prostatic Intraepithelial Neoplasia Therapeutics Clinical Trials, Global, Key Sponsors, 2014* 23
Prostatic Intraepithelial Neoplasia Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014* 24
Prostatic Intraepithelial Neoplasia Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014* 25
GlobalData Methodology 68

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
Clinical Trial Management System Market by End-user, Delivery Mode, Type, Component - Global Forecast to 2021

Clinical Trial Management System Market by End-user, Delivery Mode, Type, Component - Global Forecast to 2021

  • $ 5650
  • Industry report
  • August 2016
  • by MarketsandMarkets

The global clinical trial management system (CTMS) market is estimated to grow at a CAGR of 11.5% from 2016 to 2021, to reach USD 920.0 billion by 2021. The adoption of CTMS software is on the rise across ...

Contract Research Organizations Services Market by Type, Therapeutic Area, End User - Global Forecast to 2021

Contract Research Organizations Services Market by Type, Therapeutic Area, End User - Global Forecast to 2021

  • $ 5650
  • Industry report
  • October 2016
  • by MarketsandMarkets

The global CRO services market is estimated to grow at a CAGR of 7.4% from 2016 to 2021, to reach USD 41.86 billion by 2021 from USD 29.29 billion in 2016. Growth in this market is primarily attributed ...

Clinical Trial Management System (CTMS) - Global Market Outlook (2016-2022)

Clinical Trial Management System (CTMS) - Global Market Outlook (2016-2022)

  • $ 4157
  • Industry report
  • November 2016
  • by Stratistics MRC

According to Stratistics MRC, the Global Clinical Trial Management System (CTMS) market is expected to grow from $493.58 million in 2015 to reach $1118.58 million by 2022 with a CAGR of 12.4%. Huge research ...


ref:plp2014

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.